In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption

Bone

Volumn 49, Issue 2, 2011, Pages 174-183

  Dong, X Neil ^a   Qin, An ^b,c   Xu, Jiake ^b   Wang, Xiaodu ^d  

^a UNIVERSITY OF TEXAS AT TYLER   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d The University of Texas at San Antonio   (United States)

Author keywords

Advanced glycation endproducts; Bone resorption; Immunohistochemistry; Osteoclast; Pentosidine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; PENTOSIDINE;

ADULT; AGED; ARTICLE; BIOACCUMULATION; BONE MATRIX; BONE REMODELING; BONE TISSUE; CADAVER; CARBOHYDRATE ANALYSIS; CELL CULTURE; CONTROLLED STUDY; CORRELATIONAL STUDY; CORTICAL BONE; EPIFLUORESCENCE MICROSCOPY; FEMUR; FLUORESCENCE ANALYSIS; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OSTEOCLAST ACTIVITY; OSTEOLYSIS; SPECTRAL SENSITIVITY; TISSUE DISTRIBUTION;

ADULT; AGE FACTORS; AGED; ARGININE; BONE MATRIX; BONE RESORPTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; LYSINE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; OSTEOCLASTS;

EID: 79958771169     PISSN: 87563282     EISSN: 87563282     Source Type: Journal    
DOI: 10.1016/j.bone.2011.04.009     Document Type: Article

References (62)

1. Monnier V.M., Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981, 211:491-493.
2. Hein G., Weiss C., Lehmann G., Niwa T., Stein G., Franke S. Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 2006, 65:101-104.
3. Bailey A.J., Paul R.G., Knott L. Mechanisms of maturation and ageing of collagen. Mech Ageing Dev 1998, 106:1-56.
4. DeGroot J. The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol 2004, 4:301-305.
5. Sell D.R., Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 1989, 264:21597-21602.
6. Katayama Y., Celic S., Nagata N., Martin T.J., Findlay D.M. Nonenzymatic glycation of type I collagen modifies interaction with UMR 201-10B preosteoblastic cells. Bone 1997, 21:237-242.
7. McCarthy A.D., Etcheverry S.B., Bruzzone L., Lettieri G., Barrio D.A., Cortizo A.M. Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress. BMC Cell Biol 2001, 2:16.
8. McCarthy A.D., Etcheverry S.B., Cortizo A.M. Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetol 2001, 38:113-122.
9. McCarthy A.D., Uemura T., Etcheverry S.B., Cortizo A.M. Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. Int J Biochem Cell Biol 2004, 36:840-848.
10. Yamamoto T., Ozono K., Miyauchi A., Kasayama S., Kojima Y., Shima M., et al. Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy. Am J Kidney Dis 2001, 38:S161-S164.
11. Alikhani M., Alikhani Z., Boyd C., MacLellan C.M., Raptis M., Liu R., et al. Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone 2007, 40:345-353.
12. Mercer N., Ahmed H., Etcheverry S.B., Vasta G.R., Cortizo A.M. Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells. Mol Cell Biochem 2007, 306:87-94.
13. Miyata T., Notoya K., Yoshida K., Horie K., Maeda K., Kurokawa K., et al. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 1997, 8:260-270.
14. Valcourt U., Merle B., Gineyts E., Viguet-Carrin S., Delmas P.D., Garnero P. Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 2007, 282:5691-5703.
15. Yeni Y.N., Schaffler M.B., Gibson G., Fyhrie D.P. Prestress due to dimensional changes caused by demineralization: a potential mechanism for microcracking in bone. Ann Biomed Eng 2002, 30:217-225.
16. Wang X., Shen X., Li X., Agrawal C.M. Age-related changes in the collagen network and toughness of bone. Bone 2002, 31:1-7.
17. Nyman J.S., Roy A., Acuna R.L., Gayle H.J., Reyes M.J., Tyler J.H., et al. Age-related effect on the concentration of collagen crosslinks in human osteonal and interstitial bone tissue. Bone 2006, 39:1210-1217.
18. Firschein H.E., Shill J.P. The determination of total hydroxyproline in urine and bone extracts. Anal Biochem 1966, 14:296-304.
19. Stegemann H., Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967, 18:267-273.
20. Creemers L.B., Jansen D.C., van Veen-Reurings A., van den Bos T., Everts V. Microassay for the assessment of low levels of hydroxyproline. Biotechniques 1997, 22:656-658.
21. Hartles R.L., Leaver A.G. The fluorescence of teeth under ultraviolet irradiation. Biochem J 1953, 54:632-638.
22. Mclean F.C., Urist M.R. Bone: fundamentals of the physiology of skeletal tissue 1968, University of Chicago Press.
23. Prentice A.I. Bone autofluorescence and mineral content. Nature 1965, 206:1167.
24. Prentice A.I. Autofluorescence of bone tissues. J Clin Pathol 1967, 20:717-719.
25. Armstrong W.G., Horsley H.J. Isolation of fluorescent components from ox-bone human dentine and gelatin. Nature 1966, 211:981.
26. Armstrong W.G., Horsley H.J. Isolation and properties of fluorescent components associated with calcified tissue collagen. Calcif Tissue Res 1972, 8:197-210.
27. Vashishth D., Gibson G.J., Khoury J.I., Schaffler M.B., Kimura J., Fyhrie D.P. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 2001, 28:195-201.
28. Gibson G., Glotkowski M., Fyhrie D., Schaffler M.B., Les C.M., Tashman S. Fluorescence provides a measure of local tissue age and remodeling history in human cortical bone. Transactions of the 46th Annual Meeting of Orthopaedic Research Society 2000, 25:691.
29. Saito M., Fujii K., Soshi S., Tanaka T. Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 2006, 17:986-995.
30. Semba R.D., Nicklett E.J., Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype?. J Gerontol A Biol Sci Med Sci 2010, 65:963-975.
31. Hamada Y., Fujii H., Fukagawa M. Role of oxidative stress in diabetic bone disorder. Bone 2009, 45(Suppl 1):S35-S38.
32. Almeida M., Han L., Martin-Millan M., Plotkin L.I., Stewart S.A., Roberson P.K., et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 2007, 282:27285-27297.
33. Sell D.R., Lane M.A., Johnson W.A., Masoro E.J., Mock O.B., Reiser K.M., et al. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci U S A 1996, 93:485-490.
34. Baynes J.W. The role of AGEs in aging: causation or correlation. Exp Gerontol 2001, 36:1527-1537.
35. Dyer D.G., Dunn J.A., Thorpe S.R., Bailie K.E., Lyons T.J., McCance D.R., et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993, 91:2463-2469.
36. Odetti P., Rossi S., Monacelli F., Poggi A., Cirnigliaro M., Federici M., et al. Advanced glycation end products and bone loss during aging. Ann NY Acad Sci 2005, 1043:710-717.
37. Saito M., Marumo K., Fujii K., Ishioka N. Single-column high-performance liquid chromatographic-fluorescence detection of immature, mature, and senescent cross-links of collagen. Anal Biochem 1997, 253:26-32.
38. Hernandez C.J., Tang S.Y., Baumbach B.M., Hwu P.B., Sakkee A.N., van der Ham F., et al. Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone 2005, 37:825-832.
39. Tang S.Y., Allen M.R., Phipps R., Burr D.B., Vashishth D. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int 2009, 20:887-894.
40. Allen M.R., Gineyts E., Leeming D.J., Burr D.B., Delmas P.D. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int 2008, 19:329-337.
41. Frost H.M. Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's law: the remodeling problem. Anat Rec 1990, 226:414-422.
42. Zhou H., Chernecky R., Davies J.E. Deposition of cement at reversal lines in rat femoral bone. J Bone Miner Res 1994, 9:367-374.
43. Schaffler M.B., Burr D.B., Frederickson R.G. Morphology of the osteonal cement line in human bone. Anat Rec 1987, 217:223-228.
44. Burr D.B., Schaffler M.B., Frederickson R.G. Composition of the cement line and its possible mechanical role as a local interface in human compact bone. J Biomech 1988, 21:939-945.
45. Skedros J.G., Holmes J.L., Vajda E.G., Bloebaum R.D. Cement lines of secondary osteons in human bone are not mineral-deficient: new data in a historical perspective. Anat Rec A Discov Mol Cell Evol Biol 2005, 286:781-803.
46. Nanci A. Content and distribution of noncollagenous matrix proteins in bone and cementum: relationship to speed of formation and collagen packing density. J Struct Biol 1999, 126:256-269.
47. Davies J.E. Bone bonding at natural and biomaterial surfaces. Biomaterials 2007, 28:5058-5067.
48. Frasca P. Scanning-electron microscopy studies of 'ground substance' in the cement lines, resting lines, hypercalcified rings and reversal lines of human cortical bone. Acta Anat (Basel) 1981, 109:115-121.
49. McKee M.D., Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Tech 1996, 33:141-164.
50. McKee M.D., Zalzal S., Nanci A. Extracellular matrix in tooth cementum and mantle dentin: localization of osteopontin and other noncollagenous proteins, plasma proteins, and glycoconjugates by electron microscopy. Anat Rec 1996, 245:293-312.
51. Nakamura H., Ozawa H. Characteristic localization of carbohydrates in osteoclasts by lectin cytochemistry. Bone 1992, 13:411-416.
52. Romano P.R., Caton J.G., Puzas J.E. The reversal line may be a key modulator of osteoblast function: observations from an alveolar bone wound-healing model. J Periodontal Res 1997, 32:143-147.
53. Kagayama M., Sasano Y., Akita H. Lectin binding in bone matrix of adult rats with special reference to cement lines. Tohoku J Exp Med 1993, 170:81-91.
54. Tang S.Y., Zeenath U., Vashishth D. Effects of non-enzymatic glycation on cancellous bone fragility. Bone 2007, 40:1144-1151.
55. Biemel K.M., Friedl D.A., Lederer M.O. Identification and quantification of major maillard cross-links in human serum albumin and lens protein. Evidence for glucosepane as the dominant compound. J Biol Chem 2002, 277:24907-24915.
56. Biemel K.M., Reihl O., Conrad J., Lederer M.O. Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: unraveling the structure of a pentosidine precursor. J Biol Chem 2001, 276:23405-23412.
57. Sell D.R., Biemel K.M., Reihl O., Lederer M.O., Strauch C.M., Monnier V.M. Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem 2005, 280:12310-12315.
58. Saito M., Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 2010, 21:195-214.
59. Zioupos P., Currey J.D., Hamer A.J. The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res 1999, 45:108-116.
60. Fujii K., Kuboki Y., Sasaki S. Aging of human bone and articular cartilage collagen: changes in the reducible cross-links and their precursors. Gerontology 1976, 22:363-370.
61. Eyre D.R., Dickson I.R., Van Ness K. Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem J 1988, 252:495-500.
62. Bailey A.J., Sims T.J., Ebbesen E.N., Mansell J.P., Thomsen J.S., Mosekilde L. Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int 1999, 65:203-210.